There are concerns people are getting their hands on medicinal cannabis to treat conditions where there's very little evidence of benefit — and the possibility of harm. 

Also, why weight loss drugs could improve treatment for people with schizophrenia. The full breadth of corporate ownership of radiology clinics is revealed. 

And what questions need to be asked with IVF in the spotlight, as Monash IVF deals with the fallout from a second bungled embryo transfer.

References:

• Medicinal cannabis prescribing practices under scrutiny after scripts issued 'every 4 minutes' - ABC News
• ‘Infuriating and dangerous’: Psychiatrist tries and fails to speak with his patients’ medicinal cannabis prescribers - AusDoc.
• Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia
• Corporatisation and ownership concentration in diagnostic imaging: an audit of Australian practices